Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Citizens JMP analyst reiterated a Market Perform rating on Piper Sandler (NYSE:PIPR), currently valued at $5.3 billion, in a research note released Monday. According to InvestingPro data, three analysts have recently revised their earnings estimates upward for the upcoming period.
JMP expressed confidence in Piper Sandler’s momentum heading into the second half of the year and highlighted the firm’s competitive positioning as it continues to expand its service offerings. The company’s strong positioning is reflected in its impressive 30% return over the past year and robust revenue growth of 10.7%.
The research note specifically mentioned Monday’s announcement of Piper Sandler’s acquisition of G Squared Capital as an example of the company’s ongoing expansion of capabilities for clients.
JMP suggested investor sentiment toward PIPR could further improve given its strong positioning with depositories, where market participants are increasingly optimistic about potential consolidation activity.
The stock has recovered significantly from April’s tariff-driven lows, rising more than 50% and now trading up 5% year-to-date at 17.1x JMP’s 2026 estimated earnings per share, which the firm views as a relatively balanced risk/reward valuation.
In other recent news, Piper Sandler Companies reported its financial results for the second quarter of 2025, surpassing analysts’ expectations. The company achieved an adjusted earnings per share (EPS) of $2.95, significantly higher than the projected $2.25, resulting in a 31.11% surprise. Revenue also exceeded forecasts, coming in at $396.79 million compared to the expected $355.07 million. This strong performance highlights the company’s ability to outperform market expectations in its latest quarter. Despite these positive results, the stock experienced a slight decline in pre-market trading. The financial community will likely monitor how Piper Sandler continues to navigate market conditions in the coming quarters. Investors and analysts will keep a close eye on future earnings reports to assess ongoing performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.